Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: MGV who wrote (153)	6/29/1998 4:48:00 PM
From: Jim Mac	Read Replies (2) \| Respond to of 413

Yeah, like that SBC Warburg analyst has been so accurate for the last year. Probably worrying about LZRCF's mobile plans with LASE. That analyst previously said LVCI would have ($0.48) for FY98 (April), and $0.02 for FY99. VERY wrong estimates from a highly-paid professional analyst. Now that LVCI has over 225 U.S. surgeons using its lasers, all they need to do is 3,525+ June procedures, and 3,750+ in July, on top of the 3,300 in May, at $750-1000 (mobiles charge more), while costs stay flat, and July EPS looks closer to $0.10 than $0.04. Hyperopia should get LVCI to $1.00, $1.50 on cash basis, in CY99. AG Edwards is closer to the mark with $0.71 for FY00/CY99, which probably doesn't include hyperopia.